Brown Advisory’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-3,278
| Closed | -$581K | – | 1004 |
|
|
2020
Q1 | $581K | Sell |
3,278
-11
| -0.3% | -$2.07K | ﹤0.01% | 660 |
|
|
2019
Q4 | $629K | Sell |
3,289
-41
| -1% | -$7.4K | ﹤0.01% | 721 |
|
|
2019
Q3 | $560K | Buy |
3,330
+1,456
| +78% | +$237K | ﹤0.01% | 724 |
|
|
2019
Q2 | $314K | Sell |
1,874
-17,346
| -90% | -$2.4M | ﹤0.01% | 858 |
|
|
2019
Q1 | $2.81M | Sell |
19,220
-378
| -2% | -$54.8K | 0.01% | 561 |
|
|
2018
Q4 | $2.62M | Sell |
19,598
-947
| -5% | -$155K | 0.01% | 533 |
|
|
2018
Q3 | $3.91M | Sell |
20,545
-304
| -1% | -$55.8K | 0.01% | 496 |
|
|
2018
Q2 | $3.48M | Buy |
20,849
+11,926
| +134% | +$1.91M | 0.01% | 518 |
|
|
2018
Q1 | $1.5M | Sell |
8,923
-4,522
| -34% | -$758K | ﹤0.01% | 566 |
|
|
2017
Q4 | $2.2M | Sell |
13,445
-13,359
| -50% | -$2.4M | 0.01% | 514 |
|
|
2017
Q3 | $5.49M | Buy |
26,804
+3,077
| +13% | +$716K | 0.02% | 382 |
|
|
2017
Q2 | $5.77M | Sell |
23,727
-316
| -1% | -$74.3K | 0.02% | 391 |
|
|
2017
Q1 | $5.74M | Buy |
24,043
+4,459
| +23% | +$1.04M | 0.02% | 354 |
|
|
2016
Q4 | $4.11M | Sell |
19,584
-1,785
| -8% | -$370K | 0.01% | 408 |
|
|
2016
Q3 | $4.92M | Sell |
21,369
-4,856
| -19% | -$1.19M | 0.02% | 373 |
|
|
2016
Q2 | $6.06M | Buy |
26,225
+4,264
| +19% | +$983K | 0.02% | 335 |
|
|
2016
Q1 | $5.89M | Buy |
21,961
+895
| +4% | +$256K | 0.02% | 339 |
|
|
2015
Q4 | $6.58M | Buy |
21,066
+3,590
| +21% | +$1.07M | 0.02% | 331 |
|
|
2015
Q3 | $4.75M | Buy |
17,476
+1,864
| +12% | +$573K | 0.02% | 362 |
|
|
2015
Q2 | $4.74M | Sell |
15,612
-2,816
| -15% | -$840K | 0.02% | 356 |
|
|
2015
Q1 | $5.49M | Buy |
18,428
+5,489
| +42% | +$1.56M | 0.02% | 334 |
|
|
2014
Q4 | $3.33M | Buy |
12,939
+335
| +3% | +$83.7K | 0.01% | 401 |
|
|
2014
Q3 | $3.04M | Buy |
12,604
+8,368
| +198% | +$1.87M | 0.01% | 399 |
|
|
2014
Q2 | $945K | Buy |
4,236
+8
| +0.2% | +$1.66K | ﹤0.01% | 564 |
|
|
2014
Q1 | $870K | Buy |
4,228
+78
| +2% | +$15.4K | ﹤0.01% | 557 |
|
|
2013
Q4 | $697K | Buy |
+4,150
| New | +$649K | ﹤0.01% | 578 |
|
|
2013
Q3 | – | Sell |
-3,863
| Closed | -$487K | – | 920 |
|
|
2013
Q2 | $487K | Buy |
+3,863
| New | +$437K | ﹤0.01% | 593 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Brown Advisory's AGN Position: Q2 2020 in Review
Brown Advisory sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,278 shares — an estimated $581K sold.
Brown Advisory first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $6.58M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Brown Advisory reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Brown Advisory sold 3,278 Allergan plc shares in Q2 2020, an estimated $581K.
- Brown Advisory first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
- Brown Advisory's Allergan plc position peaked at $6.58M in Q4 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Brown Advisory's 13F filing for Q2 2020, filed 14 Aug 2020.